[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@RedChip RedChip

RedChip appears to be hosting investor webinars with various companies, including Bullfrog AI ($BFRG), Calidi Biotherapeutics ($CLDI), Fathom Holdings ($FTHM), and Fibrobiologics ($FBLG). These webinars aim to provide insights into the companies' growth strategies, innovative approaches, and future prospects. RedChip also introduced RedChat, a new platform for small-cap research that provides instant answers and verified data.

Engagements: XXXXX #

X Week XXXXXX -XXXX%
X Month XXXXXXX +262%
X Months XXXXXXX +28%
X Year XXXXXXX +18%

Mentions: XX #

X Week XX +3.20%
X Month XXX +52%
X Months XXX +254%
X Year XXX +214%

Followers: XXXXX #

X Week XXXXX +0.49%
X Month XXXXX +1.50%
X Months XXXXX +7.50%
X Year XXXXX +8.80%

CreatorRank: XXXXXXX #

Social Influence #

Social category influence finance XXXXX% cryptocurrencies XXXXX% stocks XXXX% exchanges #1510 currencies XXXX% technology brands XXXX% automotive brands XXXX%

Social topic influence $fthm 8.26%, acquisition 5.5%, $110m 5.05%, $aent 3.21%, $amgn #3, $aspi #6, nasdaq #167, $aents 2.29%, pfe 1.83%, amgn XXXX%

Top accounts mentioned or mentioned by @bttrchoiceco @aspisotopes @nexalintech @bioaffinity @stockinfocuz @calidibio @renergenjhb @fibrobiologics @jcventerinst @lieberinstitute @novaminerals @trinitybiotech @northwesternu @marketwirenews @nasdaq @jsegroup @venulive @paultorrescohen @srxhealth @stockminds009

Top assets mentioned Fathom Protocol (FTHM) Amgen, Inc. (AMGN) Pfizer, Inc. (PFE) AstraZeneca PLC (AZN) Merck & Co., Inc. (MRK) Johnson & Johnson (JNJ) Vistra, Corp. (VST) Constellation Energy Corp (CEG) NuScale Power Corporation (SMR) Oklo Inc. (OKLO) CoStar Group, Inc. (CSGP) Equinix Inc (EQIX) Gilead Sciences, Inc. (GILD) AbbVie Inc (ABBV) Moderna Inc (MRNA) Eli Lilly and Company (LLY) Regeneron Pharmaceuticals Inc (REGN) Rivian Automotive, Inc. (RIVN) Tesla, Inc. (TSLA) Levante U.D. Fan Token (LEV) Boyd Gaming Corporation (BYD) Novartis AG (NVS) GSK plc (GSK) Arrowhead Research Corporation (ARWR) Vertex Protocol (VRTX) Illumina, Inc. (ILMN) Novo-Nordisk (NVO) CRISPR Therapeutics AG (CRSP) REN (REN) Strategy (MSTR) Alphabet Inc Class A (GOOGL) Starbucks Corporation (SBUX) Celsius Holdings, Inc. Common Stock (CELH) Super Micro Computer, Inc. Common Stock (SMCI)

Top Social Posts #

Top posts by engagements in the last XX hours

"🚨 Fathom Holdings $FTHM: Unlocking Scalable Growth in Real Estate Services Fathom Holdings is redefining real estate with its agent-first flat-fee commission model and fully integrated platform spanning brokerage mortgage title and SaaS. With over 14300 agents across XX states and a path to $110M+ in added revenue from recent acquisitions $FTHM is built for scale and profitability even at transaction levels less than half of its peers. 💡 Why It Matters to Investors: - Disruptive Model: Higher agent earnings drive industry-leading growth and retention. - Operational Efficiency: Reaches"
@RedChip on X 2025-07-07 13:35:01 UTC 5584 followers, XXX engagements

"Join $FBLG leadership on our investor webinar: live now $FBLG $BMS $AMGN $LLY $AZN $MRK $NVS $PFE"
@RedChip on X 2025-07-10 20:24:43 UTC 5587 followers, XXX engagements

"RedChip Investor Webinar with BullFrog AI (Nasdaq: BFRG)"
@RedChip on X 2025-07-23 20:05:55 UTC 5588 followers, XXX engagements

"📢 Todays the Day Join FibroBiologics $FBLG at 4:15 PM EST Dive into the future of cell therapy with insights on clinical progress and strategic growth across a 160+ patent portfolio. 🔗 Join live: $FBLG $GSK $REGN $ARWR $MRK #BiotechInvestors #HealthcareInnovation #FBLG #WebinarAlert"
@RedChip on X 2025-07-10 16:29:06 UTC 5583 followers, XXX engagements

"Join $CLDI's CEO on our investor webinar: live now $AMGN $JNJ $CADL $NVO $LLY $CRSP $ILMN $PFE $VRTX $REGN"
@RedChip on X 2025-07-24 20:21:58 UTC 5588 followers, XXX engagements

"🎙 Fathom Holdings $FTHM CEO Interview: A Must-Watch for Growth-Oriented Investors $FTHM CEO Marco Fregenal shares his vision for disrupting real estate through technology efficiency and agent empowerment. With over 14300 agents across XX states and the recent acquisition of My Home Group Fathom is executing a strategy that blends scale with profitability. 💡 Why This Matters to Investors: - $110M Revenue Boost expected from My Home Group in 2025. - EBITDA Breakeven at Just 45000 Transactions half the volume of peers. - Expanding to All XX States and Canada targeting major market share gains."
@RedChip on X 2025-07-17 13:35:01 UTC 5584 followers, XXX engagements

"🎥 ASP Isotopes $ASPI: One-Minute Insight into a High-Impact Growth Story @ASPIsotopes is pioneering the next frontier of isotope production right as global demand surges in nuclear medicine quantum computing and clean energy. Backed by $60M+ in cash and a scalable business model $ASPI is now commercializing key isotopes like Ytterbium-176 and Carbon-14 under long-term supply agreements. Why This Matters for Investors - Transition to Revenue: From R&D to commercialization in 2025 - Strategic Partnerships: Backed by TerraPower and South Africas Necsa - Breakthrough Technology: Proprietary"
@RedChip on X 2025-07-24 12:15:01 UTC 5588 followers, XXX engagements

"🎙 BullFrog AI $BFRG: Exclusive Interview with CEO Vin Singh: Unlocking the Future of AI in Drug Discovery $BFRG is changing the game for drug development and CEO Vin Singh breaks down how in this must-watch interview. From their proprietary bfLEAP technology to the launch of BullFrog Data Networks hear how the company is accelerating clinical breakthroughs and driving smarter R&D decisions especially for small and mid-sized biopharma players. Why Investors Should Tune In: - Addressing a $204B+ R&D Market with scalable AI tools that cut costs and timelines - Strategic partnerships with"
@RedChip on X 2025-07-22 12:25:16 UTC 5584 followers, XXX engagements

"🚨 Fathom Holdings $FTHM: Unlocking Scalable Growth in Real Estate Services Fathom Holdings is redefining real estate with its agent-first flat-fee commission model and fully integrated platform spanning brokerage mortgage title and SaaS. With over 14300 agents across XX states and a path to $110M+ in added revenue from recent acquisitions $FTHM is built for scale and profitability even at transaction levels less than half of its peers. Why It Matters to Investors: - Disruptive Model: Higher agent earnings drive industry-leading growth and retention. - Operational Efficiency: Reaches EBITDA"
@RedChip on X 2025-07-21 13:35:06 UTC 5584 followers, XXX engagements

"📺 Alliance Entertainment $AENT: XX Seconds on a Category Leader in Physical Media & Collectibles Alliance powers 35000+ retail locations and XXX e-commerce platforms fueling $1.1B+ in annual revenue across vinyl video games and licensed merchandise. 💡 Why Investors Should Watch: With exclusive content deals a capital-light model and leadership in high-growth collectibles $AENT is scaling efficiently at the intersection of fandom and commerce. 🎯 $AENT $FNKO $DIS $NTDOY $SONY"
@RedChip on X 2025-07-18 12:00:19 UTC 5583 followers, XXX engagements

"🏡 Fathom Holdings $FTHM: Disrupting the Brokerage Model - Find Out How This Wednesday discover how $FTHM is scaling with efficiency growing its agent base nearly 2x the national average and expanding nationwide through smart acquisitions. 💼 $110M in 2025 revenue expected from My Home Group acquisition ⚙ Proprietary platform intelliAgent driving operational gains 📈 Positioned for EBITDA breakeven at half the volume of competitors 📍 Webinar: Wed July XX 4:15PM EST 🔗 $FTHM $REAX $EQIX $CSGP"
@RedChip on X 2025-07-14 13:27:05 UTC 5584 followers, XXX engagements

"🎤 Alliance Entertainment $AENT: Executive Chairman Bruce Ogilvie on Strategy & Execution Bruce Ogilvie outlines $AENT's growth priorities: scaling higher-margin exclusive content expanding direct-to-consumer fulfillment (35% of gross revenue) and leveraging automation to enhance profitability. 💡 Why Investors Should Watch: Insight into how $AENT aligns operational execution with long-term shareholder value targeting durable growth across premium entertainment and collectibles segments. 🎯 $AENT $FNKO $SONY $DIS $NTDOY"
@RedChip on X 2025-07-10 12:00:12 UTC 5583 followers, XXX engagements

"📢 Fathom Holdings $FTHM: Disrupting Real Estate with Tech-Driven Scale and Efficiency $FTHM is redefining the real estate model with its proprietary tech platform and flat-fee commission structure empowering over 14300 agents across XX states. With the recent acquisition of My Home Group projected to add $110M+ in revenue for 2025 and EBITDA breakeven achievable at just 45000 transactions Fathom is built for sustainable scalable growth. 💡 Why It Matters to Investors: 📊 Revenue Synergy: My Home Group boosts topline growth and expands national footprint. 💸 Agent-Centric Model: Doubles"
@RedChip on X 2025-07-04 13:35:02 UTC 5584 followers, XXX engagements

"🚨 ASP Isotopes $ASPI: Renergen Shareholders Approve Transformational Acquisition 📢 XXXX% of @RenergenJHB $REN shareholders voted in favor of the proposed acquisition by @ASPIsotopes advancing a deal that could reshape the global supply chain for helium LNG and enriched isotopes. 💡 Why This Matters for Investors: ✅ Strategic Expansion: Combines $ASPI's innovative enrichment technology with Renergens helium and LNG operations creating a vertically integrated advanced materials company. ✅ U.S. Government-Backed Assets: Renergens helium reserves already funded by the U.S. government are"
@RedChip on X 2025-07-11 13:57:01 UTC 5584 followers, XXX engagements

"Clinical decisions are only as good as the data behind them. $BIAF's CyPath Lung empowers pulmonologists to make informed decisions when faced with indeterminate nodules. By confirming or excluding malignancy early it helps avoid unnecessary CT scans biopsies and delays in care. This is precision diagnostics in practice. Learn more: $BIAF $AZN $KURA $PFE $AMGN #BIAF #CyPathLung #lungcancer #ScreeningSavesLives #lungnodule #pulmonology"
@RedChip on X 2025-07-08 20:25:13 UTC 5586 followers, XXX engagements

"Starts in XX Minutes: Phoenix Motor $PEVM Investor Webinar Last chance to join and hear how $PEVM is driving the future of electric mobility. 📍 $PEVM $BYD $LEV $TSLA $RIVN #EVStocks #WebinarLive #PEV"
@RedChip on X 2025-07-01 20:00:17 UTC 5584 followers, XXX engagements

"🚨 Investor Reminder: Fathom Holdings $FTHM Webinar Is Tomorrow Don't miss this opportunity to hear from one of the most innovative players in real estate services. $FTHM is combining high-margin efficiency with strategic growth and digital innovation. ✔ Flat-fee model = agent loyalty + margin advantage ✔ Technology-owned infrastructure reduces overhead ✔ Positioned to capitalize on housing market rebound 📍 LIVE: Wednesday July XX 4:15PM EST 🔗 $FTHM $REAX $EQIX $CSGP"
@RedChip on X 2025-07-15 15:35:07 UTC 5584 followers, XXX engagements

"🔔 Webinar Alert: Learn Why Fathom Holdings $FTHM Is Reshaping Real Estate Join us next Wednesday to hear how $FTHM's tech-driven platform flat-fee model and $110M+ acquisition strategy are redefining profitability in the housing market. 📊 Integrated mortgage title SaaS and brokerage services 🏠 Operating in XX states with 14700+ agents 💰 Positioned for EBITDA breakeven at half the volume of competitors 📍 Live Webinar Wed July XX at 4:15PM EST 🔗 $FTHM $REAX $EQIX $CSGP"
@RedChip on X 2025-07-11 17:10:48 UTC 5584 followers, XXX engagements

"🧬 @bioAffinity $BIAF: CyPath Lung Flags Cancer Missed by Traditional Tools A new case study highlights how CyPath Lung identified a Stage 1A neuroendocrine tumor that went undetected by PET scans bronchoscopy and serum tests underscoring its diagnostic value for early-stage lung cancer. Why This Matters to Investors: - Clinical Validation: The patient was cleared by multiple diagnostics before CyPath Lung flagged a high cancer probability (score: 0.72) leading to successful early surgical intervention. - Addressing Diagnostic Gaps: Neuroendocrine tumors are notoriously hard to detect with"
@RedChip on X 2025-07-23 13:43:29 UTC 5588 followers, XXX engagements

"🎥 CEO Interview Spotlight: Jupiter Neurosciences $JUNS Charts Bold Path in CNS Therapeutics Jupiter CEO Christer Rosn shares strategic insights in a new interview covering the companys innovative approach to treating neuroinflammation and rare diseases. Key Highlights for Investors: - JOTROL Advantage: 9x greater bioavailability than traditional resveratrol positioned for major impact in Alzheimer's Parkinsons and rare CNS conditions. - Near-Term Catalysts: Multiple Phase X trials launching in 2025 plus a direct-to-consumer nutraceutical strategy targeting the $50B+ longevity market. -"
@RedChip on X 2025-07-24 13:55:01 UTC 5588 followers, XX engagements

"🎙 Investor Spotlight: Exclusive Interview with Nexalin Technology $NXL CEO Mark White @NexalinTech is advancing mental health treatment with its proprietary Deep Intracranial Frequency Stimulation (DIFS) offering a non-invasive drug-free solution to conditions like depression PTSD and systemic health issues. 💡 Why This Matters to Investors: - Breakthrough Tech: Gen-3 HALO Clarity headset targets deep brain structures: no drugs no side effects. - Clinical Momentum: Backed by 29+ trials and peer-reviewed research showing blood pressure reduction in depressive patients. - Global Growth:"
@RedChip on X 2025-07-14 14:30:11 UTC 5593 followers, XXX engagements

"🧪 Investor Spotlight: Exclusive Interview with Nexalin Technology $NXL CEO Mark White @NexalinTech is advancing mental health treatment with its proprietary Deep Intracranial Frequency Stimulation (DIFS) offering a non-invasive drug-free solution to conditions like depression PTSD and systemic health issues. Why This Matters to Investors: - Breakthrough Tech: Gen-3 HALO Clarity headset targets deep brain structures: no drugs no side effects. - Clinical Momentum: Backed by 29+ trials and peer-reviewed research showing blood pressure reduction in depressive patients. - Global Growth:"
@RedChip on X 2025-07-21 14:30:10 UTC 5592 followers, XXX engagements

"📢 Unlock the Future of Cancer Treatment in Just XX Seconds @CalidiBio $CLDI invites investors to watch its brief company overview video spotlighting its next-gen immuno-oncology platforms designed to target high-impact cancer markets worth up to $XX billion annually. Why It Matters for Investors: - Multiple Clinical Programs: Advancing treatments for glioblastoma triple-negative breast cancer lung cancer and more. - Breakthrough Delivery Platforms: Protect and enhance the power of oncolytic viruses improving patient outcomes. - Strong Pipeline & Analyst Confidence: Three buy ratings with an"
@RedChip on X 2025-07-21 12:55:06 UTC 5588 followers, XXX engagements

"🧬 FibroBiologics $FBLG Advancing Cell Therapy for Chronic Diseases @FibroBiologics is pioneering next-generation cell therapy using fibroblast cells to target some of the worlds most challenging chronic conditions: from multiple sclerosis and psoriasis to disc degeneration wound healing and even cancer. 💡 Why This Matters to Investors: ✅ Extensive IP Portfolio: 160+ U.S. and international patents and patents pending across diverse clinical pathways. ✅ Broad Pipeline Potential: Targeting high-need markets in orthopedics neurology oncology and regenerative medicine. ✅ Innovative Platform:"
@RedChip on X 2025-07-18 15:20:02 UTC 5588 followers, XXX engagements

"🎙 Fathom Holdings $FTHM CEO Interview: A Must-Watch for Growth-Oriented Investors $FTHM CEO Marco Fregenal shares his vision for disrupting real estate through technology efficiency and agent empowerment. With over 14300 agents across XX states and the recent acquisition of My Home Group Fathom is executing a strategy that blends scale with profitability. Why This Matters to Investors: - $110M Revenue Boost expected from My Home Group in 2025. - EBITDA Breakeven at Just 45000 Transactions half the volume of peers. - Expanding to All XX States and Canada targeting major market share gains. -"
@RedChip on X 2025-07-24 13:35:01 UTC 5588 followers, XX engagements

"📢 Fathom Holdings $FTHM: Disrupting Real Estate with Tech-Driven Scale and Efficiency $FTHM is redefining the real estate model with its proprietary tech platform and flat-fee commission structureempowering over 14300 agents across XX states. With the recent acquisition of My Home Group projected to add $110M+ in revenue for 2025 and EBITDA breakeven achievable at just 45000 transactions Fathom is built for sustainable scalable growth. 💡 Why It Matters to Investors: 📊 Revenue Synergy: My Home Group boosts topline growth and expands national footprint. 💸 Agent-Centric Model: Doubles"
@RedChip on X 2025-06-20 13:35:01 UTC 5592 followers, XXX engagements

"🔬 bioAffinity Technologies $BIAF: CyPath Lung Detects Early-Stage Cancer Where Imaging Fell Short A new case study highlights CyPath Lung's potential to change lung cancer diagnostics. The noninvasive test identified Stage 1A adenocarcinoma in a high-risk patient whose CT and PET scans showed inconclusive or low-probability results. 💡 Why This Matters to Investors: - Proven Clinical Impact: Detected cancer in a case where standard imaging failed allowing for early surgical intervention and likely saving a life. - Cost-Saving Potential: Peer-reviewed analysis estimates up to $370M in"
@RedChip on X 2025-07-09 13:34:18 UTC 5591 followers, XXX engagements

"🚨 Starting Soon: Fathom Holdings $FTHM Investor Webinar Discover how Fathom is scaling profitably and redefining real estate with tech and innovation. 🔗 $FTHM $REAX $EQIX $CSGP"
@RedChip on X 2025-07-16 20:00:14 UTC 5584 followers, XXX engagements

"🚨 A new era of small-cap research is here. Meet RedChat. Gone are the days of sifting through endless filings. Now you can ask and get answers instantly. Verified data pulled straight from SEC filings Lightning-fast answers to support due diligence and risk management Zero friction. Maximum edge. Download Now on iOS & Google Play $SBUX $CELH $AMEH $AVNR $UUUU $SMCI $MSTR $SOUN $MARA $IONQ $RIOT $AUR $JOBY $SMR $HIMS $RCAT $AENT $NXL $UMAC $GRRR $ASPI $NVA $MOB $MLSS"
@RedChip on X 2025-07-22 14:49:19 UTC 5583 followers, XXX engagements

"✅ Gorilla Technology $GRRR Concludes Legal Action Against Culper Research "We are pleased to put this matter behind us. Gorilla has spent this year doing what matters most executing our strategy and delivering results. With over $XXX billion in active pipeline new capital secured and a growing global customer base we are not just moving forward we are accelerating. - Jay Chandan Chairman & CEO Read the Full Announcement: $GRRR $DGII $CSCO $MSFT $HON"
@RedChip on X 2025-07-21 13:00:38 UTC 5583 followers, XXX engagements

"⚛ Jupiter Neurosciences $JUNS: JOTROL Delivers 9x Bioavailability Targets CNS Breakthroughs $JUNS is redefining resveratrols therapeutic potential with JOTROL its patented formulation that solves the compounds biggest challenge: bioavailability. In Phase I trials JOTROL achieved a nine-fold increase in absorption with no GI side effects unlocking systemic dosing for CNS disorders like Parkinsons and Alzheimers. Why It Matters for Investors: - CNS Penetration: Proven ability to cross the blood-brain barrier a major milestone for treating neurodegenerative diseases - IP Strength: Patent"
@RedChip on X 2025-07-23 13:51:41 UTC 5588 followers, XXX engagements

"📢 Alliance Entertainment $AENT: Amanda Gnecco Appointed as Chief Financial Officer Prior to her promotion to CFO Amanda served as Chief Accounting Officer of Alliance playing a pivotal role in $AENT's transformation from private to public. Why This Matters to Investors: - Proven Track Record: Joined $AENT in 2018 - Strengthened Leadership: Her promotion allows CEO Jeff Walker who previously also held the role of CFO to focus solely on growth and innovation. Read the Full Announcement: $AENT $FNKO $SONY $DIS $NTDOY"
@RedChip on X 2025-07-23 13:56:18 UTC 5588 followers, XX engagements

"🚨 Fathom Holdings $FTHM: Unlocking Scalable Growth in Real Estate Services Fathom Holdings is redefining real estate with its agent-first flat-fee commission model and fully integrated platform spanning brokerage mortgage title and SaaS. With over 14300 agents across XX states and a path to $110M+ in added revenue from recent acquisitions $FTHM is built for scale and profitabilityeven at transaction levels less than half of its peers. 💡 Why It Matters to Investors: - Disruptive Model: Higher agent earnings drive industry-leading growth and retention. - Operational Efficiency: Reaches EBITDA"
@RedChip on X 2025-06-23 13:35:01 UTC 5584 followers, XXX engagements

"🚨 Live Now: Phoenix Motor $PEVM Webinar Join here 👉 $PEVM $BYD $LEV $TSLA $RIVN #PEVM #EVStocks #LiveWebinar"
@RedChip on X 2025-07-01 20:15:07 UTC 5584 followers, XXX engagements

"🎥 Exclusive Interview with Processa Pharmaceuticals CEO George Ng Processa $PCSA is taking a bold approach to oncology: modifying FDA-approved cancer drugs to create safer more effective treatments through its Next Generation Cancer (NGC) pipeline. 💡 Why Investors Should Watch: ✅ De-risked Strategy: Building on proven cancer therapies ✅ Streamlined Path: Leveraging a Regulatory Science Approach to fast-track development ✅ Market Opportunity: Targeting multi-billion-dollar oncology markets with improved tolerability for patients 📈 Could $PCSA be positioned for a major value unlock as its"
@RedChip on X 2025-07-22 15:20:13 UTC 5588 followers, XXX engagements

"🛡 Safety Sets $APVO's APVO436 Apart in AML Treatment Safety is a critical differentiator for immunotherapies. Remarkably $APVO's data show that none of the patients treated with APVO436 experienced cytokine release syndrome (CRS) a common and serious side effect of T-cell engaging therapies. This clean safety profile stems from APVO436s carefully engineered design and positions it as a well-tolerated AML treatment. Why It Matters: No CRS events: In the RAINIER trial to date no patients have experienced CRS when treated with APVO436 plus standard therapy a highly unusual outcome for a"
@RedChip on X 2025-07-22 12:10:11 UTC 5588 followers, XXX engagements

"Pop Mart the $40B collectibles giant behind Labudu sees profit soar 350%. Could $AENT's Handmade by Robots be the next craze 🔗 $AENT $PMRTY $FNKO $SONY $DIS $NTDOY"
@RedChip on X 2025-07-17 12:58:47 UTC 5585 followers, XXX engagements

"🔔 BullFrog AI $BFRG Webinar Starts in XX Minutes Join now to explore how AI is reshaping biopharma R&D. 🔗 @JCVenterInst @LieberInstitute $BFRG $ABBV $GILD $MRNA"
@RedChip on X 2025-07-23 20:00:13 UTC 5588 followers, XXX engagements

"Today at 4:15PM EST: Bullfrog AI $BFRG Investor Webinar Gain insight into how AI is changing the future of drug development: direct from $BFRG's CEO Vin Singh. 🔗 Register before it starts: @JCVenterInst @LieberInstitute $BFRG $ABBV $GILD $MRNA"
@RedChip on X 2025-07-23 13:48:09 UTC 5588 followers, XXX engagements

"🔍 CEO Interview: ASP Isotopes $ASPI CEO Paul Mann Shares Vision for Disrupting the Global Isotope Market From healthcare to quantum computing to next-gen nuclear energy @ASPIsotopes is tackling critical global supply gaps with innovative enrichment technologies. Key Insights from the Interview: - Commercialization Milestone: Three isotopes now in production: Ytterbium-176 Carbon-14 and Silicon-28 each under multi-year supply agreements. - Strategic Advantage: Quantum Enrichment and Aerodynamic Separation offer faster cleaner and lower-cost production. - Global Impact: Partnered with"
@RedChip on X 2025-07-22 12:15:06 UTC 5588 followers, 1574 engagements

"🎥 30-Second Investor Snapshot on Trinity Biotech $TRIB @TrinityBiotech is making bold moves in diagnostics and diabetes care expanding into the high-growth wearable biosensor market. 📊 Why This Matters for Investors: Strategic Expansion: Recent acquisition of Waveforms biosensor assets positions $TRIB to tap into the booming continuous glucose monitoring (CGM) space. Global Reach: Active in 75+ countries with established diagnostic products targeting infectious diseases and diabetes management. Growth Potential: Combining clinical diagnostics with wearable tech for long-term revenue"
@RedChip on X 2025-07-15 15:00:14 UTC 5584 followers, XXX engagements

"Why are investors paying closer attention to @bioAffinity $BIAF Because it checks the boxes: clinical validation insurance reimbursement commercial momentum and health system impact. CyPath Lung is more than a test: its a platform for building long-term diagnostic value. Learn more: $BIAF $AZN $KURA $PFE $AMGN #BIAF #CyPathLung #lungcancer #ScreeningSavesLives #lungnodule #pulmonology"
@RedChip on X 2025-07-18 12:30:04 UTC 5584 followers, XXX engagements

"🔬 Trinity Biotech $TRIB: Launches CGM+ to Target $260B AI Wearables Market $TRIB has unveiled CGM+ its next-gen AI-native biosensor platform designed to revolutionize continuous glucose monitoring by integrating glucose heart temperature and motion tracking into a single modular wearable. Why This Matters for Investors: - Massive Market Opportunity: Positioned at the intersection of three high-growth sectors: AI in healthcare ($200B by 2030) CGM ($28.7B by 2030) and wearable AI ($260B by 2032). - Platform Play: CGM+ offers recurring revenue potential through device sales AI-driven analytics"
@RedChip on X 2025-07-24 13:18:46 UTC 5588 followers, XXX engagements

"👀 $NVA $TECK $KGC $USGO $NG $THM $WRN $HL $GPH $NST $FVL $CTGO $XAU $XAUUSD"
@RedChip on X 2025-07-14 13:20:54 UTC 5584 followers, XXX engagements

"Starting Soon: @CalidiBio $CLDI Investor Webinar Tune in live at 4:15PM EST - last chance to join: @CIRMnews @NorthwesternU @CityofHope @TheLancet $CLDI $AMGN $JNJ $CADL"
@RedChip on X 2025-07-24 20:00:16 UTC 5588 followers, XXX engagements

"🎥 Now Live: Exclusive Interview with Processa Pharmaceuticals CEO George Ng Processa $PCSA is taking a bold approach to oncology: modifying FDA-approved cancer drugs to create safer more effective treatments through its Next Generation Cancer (NGC) pipeline. 💡 Why Investors Should Watch: ✅ De-risked Strategy: Building on proven cancer therapies ✅ Streamlined Path: Leveraging a Regulatory Science Approach to fast-track development ✅ Market Opportunity: Targeting multi-billion-dollar oncology markets with improved tolerability for patients 📈 Could $PCSA be positioned for a major value unlock"
@RedChip on X 2025-07-14 18:07:49 UTC 5592 followers, XXX engagements

"🚨 MEI Pharma $MEIP Makes Digital Asset History with $100M Private Placement Focused on Litecoin MEI Pharma has announced a $100M PIPE to launch a Litecoin $LTC treasury strategy becoming the first and only publicly traded U.S. company to hold LTC as a reserve asset on a national exchange. Why This Matters for Investors: - Institutional Confidence: Led by Litecoin creator Charlie Lee (joining $MEIP's Board) and digital asset firm GSR (appointed Asset Manager). - Strategic Digital Pivot: XXX% of proceeds to be used for $LTC acquisition aligning $MEIP's treasury with a proven decentralized"
@RedChip on X 2025-07-18 12:56:39 UTC 5584 followers, XXX engagements

"Join $BFRG leadership on our investor webinar: live now $BFRG $ABBV $GILD $MRNA $SDGR $RXRX $NVDA"
@RedChip on X 2025-07-23 20:25:26 UTC 5588 followers, XXX engagements

"📢 Today at 4:15PM EST: Fathom Holdings $FTHM Investor Webinar Hear how $FTHM's model is driving scale agent growth and profitability faster than traditional real estate players. Positioned for national expansion and $110M+ revenue infusion in 2025. 🧠 Integrated services 💻 Proprietary tech 📈 Strong operating leverage Live at 4:15PM EST 🔗 $FTHM $REAX $EQIX $CSGP"
@RedChip on X 2025-07-16 14:58:05 UTC 5584 followers, XX engagements

"🎥 CEO Interview Spotlight: Jupiter Neurosciences $JUNS Charts Bold Path in CNS Therapeutics Jupiter CEO Christer Rosn shares strategic insights in a new interview covering the companys innovative approach to treating neuroinflammation and rare diseases. 🧠 Key Highlights for Investors: - JOTROL Advantage: 9x greater bioavailability than traditional resveratrol positioned for major impact in Alzheimer's Parkinsons and rare CNS conditions. - Near-Term Catalysts: Multiple Phase X trials launching in 2025 plus a direct-to-consumer nutraceutical strategy targeting the $50B+ longevity market. -"
@RedChip on X 2025-07-17 13:55:01 UTC 5586 followers, XXX engagements

"Join $FTHM leadership on our investor webinar: live now $FTHM $REAX $EQIX $CSGP $ZG $MTN $COMP"
@RedChip on X 2025-07-16 20:32:40 UTC 5584 followers, XXX engagements

"🎙 Investor Spotlight: Enlivex Therapeutics $ENLV CEO Shares Game Changing Vision in New Interview Oren Hershkovitz CEO of @EnlivexT dives into the companys innovative approach to immunotherapy with Allocetra a macrophage reprogramming cell therapy targeting high-need indications like osteoarthritis and autoimmune diseases. 💡 Why Investors Should Watch: 🔬 Strong Clinical Data: Statistically significant 6-month results in knee osteoarthritis show sustained pain reduction and functional gains. 💰 High-Value Pipeline: Expansion into basal thumb osteoarthritis and psoriatic arthritis unlocks"
@RedChip on X 2025-07-18 13:20:01 UTC 5590 followers, XX engagements

"🎀 Alliance Entertainment $AENT: Limited-Edition Hello Kitty Vinyl Figure Debuts at SDCC 2025 $AENT's Handmade by Robots line launches a first-to-market Hello Kitty vinyl collectible in its signature knit-look design exclusively at San Diego Comic-Con (booth #4945). This officially licensed limited Pink edition is expected to generate strong demand among collectors and fans of Sanrios global icon. Why This Matters to Investors: - Brand Power: Leveraging Hello Kittys multibillion-dollar global presence to attract new collectors. - Exclusive Launch Strategy: Limited-edition collectibles at"
@RedChip on X 2025-07-24 13:25:07 UTC 5588 followers, XXX engagements

"🚨 Investor Alert: Join Calidi Biotherapeutics Live Investor Webinar - July XX at 4:15PM EST @CalidiBio $CLDI is pioneering next-gen cancer treatment through stem celldelivered oncolytic virotherapy: a market poised to reach $15B annually. 🔬 Key Topics: - Phase 1b/2 trial at @NorthwesternU for glioblastoma - Preclinical data showing 87%92% tumor growth inhibition - $XXXXX avg analyst price target 🎯 Discover why $CLDI is attracting investor and biopharma attention. 🔗 @CIRMnews @NorthwesternU @CityofHope @TheLancet $CLDI $AMGN $JNJ $CADL"
@RedChip on X 2025-07-17 16:05:12 UTC 5588 followers, XXX engagements